NO148887C - Fremgangsmaate til fremstilling av det krystallinske anhydrat av natriumcefamandol - Google Patents

Fremgangsmaate til fremstilling av det krystallinske anhydrat av natriumcefamandol

Info

Publication number
NO148887C
NO148887C NO764222A NO764222A NO148887C NO 148887 C NO148887 C NO 148887C NO 764222 A NO764222 A NO 764222A NO 764222 A NO764222 A NO 764222A NO 148887 C NO148887 C NO 148887C
Authority
NO
Norway
Prior art keywords
crystallinic
anhydrated
procedure
preparation
cefamandol
Prior art date
Application number
NO764222A
Other languages
English (en)
Norwegian (no)
Other versions
NO764222L (fr
NO148887B (no
Inventor
Kuo Shang Yang
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of NO764222L publication Critical patent/NO764222L/no
Publication of NO148887B publication Critical patent/NO148887B/no
Publication of NO148887C publication Critical patent/NO148887C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO764222A 1975-12-22 1976-12-13 Fremgangsmaate til fremstilling av det krystallinske anhydrat av natriumcefamandol NO148887C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,922 US4054738A (en) 1975-12-22 1975-12-22 Sodium cefamandole crystalline forms

Publications (3)

Publication Number Publication Date
NO764222L NO764222L (fr) 1977-06-23
NO148887B NO148887B (no) 1983-09-26
NO148887C true NO148887C (no) 1984-01-04

Family

ID=24578600

Family Applications (1)

Application Number Title Priority Date Filing Date
NO764222A NO148887C (no) 1975-12-22 1976-12-13 Fremgangsmaate til fremstilling av det krystallinske anhydrat av natriumcefamandol

Country Status (31)

Country Link
US (1) US4054738A (fr)
JP (2) JPS5282714A (fr)
AR (1) AR213300A1 (fr)
AT (2) AT349148B (fr)
AU (1) AU505924B2 (fr)
BE (1) BE849415A (fr)
CA (1) CA1080696A (fr)
CH (1) CH628348A5 (fr)
CS (1) CS195746B2 (fr)
DD (1) DD128727A5 (fr)
DE (1) DE2654647C2 (fr)
DK (1) DK153156C (fr)
FI (1) FI66008C (fr)
FR (3) FR2361898A1 (fr)
GB (1) GB1565854A (fr)
GR (1) GR65891B (fr)
HU (1) HU172474B (fr)
IL (3) IL50977A (fr)
LU (1) LU76435A1 (fr)
MX (1) MX3840E (fr)
NL (1) NL187483C (fr)
NO (1) NO148887C (fr)
NZ (1) NZ182694A (fr)
OA (1) OA05518A (fr)
PH (1) PH12191A (fr)
PL (1) PL102739B1 (fr)
PT (1) PT65955B (fr)
RO (3) RO75963A (fr)
SE (3) SE424730B (fr)
SU (3) SU637087A3 (fr)
ZA (1) ZA766957B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4168376A (en) * 1978-06-05 1979-09-18 Eli Lilly And Company Process for crystalline sodium cefamandole
US4237279A (en) * 1979-07-27 1980-12-02 Eli Lilly And Company Crystalline 3-hydroxycephalosporin solvates
DE3313818A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
DE3313816A1 (de) * 1983-04-16 1984-10-18 Hoechst Ag, 6230 Frankfurt Neue kristallmodifikation von ceftazidim
CA1242699A (fr) * 1985-02-01 1988-10-04 Bristol-Myers Company Cefbuperazone et ses derives
JPH0677412B2 (ja) * 1985-05-03 1994-09-28 株式会社フジクラ 高圧直流送電用電力ケーブル
JPS629495U (fr) * 1985-07-01 1987-01-21
GB9717629D0 (en) 1997-08-21 1997-10-22 Johnson Matthey Plc Removal of residual organic solvents

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3496171A (en) * 1969-02-17 1970-02-17 Lilly Co Eli Process for improving the physical and chemical properties of cephaloglycin
US3641021A (en) * 1969-04-18 1972-02-08 Lilly Co Eli 3 7-(ring-substituted) cephalosporin compounds
US3692781A (en) * 1971-02-26 1972-09-19 Glaxo Lab Ltd Recovery of pure cephalexin from acidic reaction mixtures
US3819620A (en) * 1972-06-01 1974-06-25 Squibb & Sons Inc 7-(d-alpha-amino-1,4-cyclohexadien-1-ylacet-amido)desacetoxycephalosporanic acid dihydrate
US3862186A (en) * 1972-12-15 1975-01-21 Bristol Myers Co Process for the production of cephalexin monohydrate
US3928592A (en) * 1974-02-22 1975-12-23 Lilly Co Eli Antibiotic pharmaceutical compositions

Also Published As

Publication number Publication date
SU1018585A3 (ru) 1983-05-15
NL187483B (nl) 1991-05-16
NL187483C (nl) 1991-10-16
SU637087A3 (ru) 1978-12-05
FR2351985B1 (fr) 1980-06-27
FI66008B (fi) 1984-04-30
AU505924B2 (en) 1979-12-06
JPS61351B2 (fr) 1986-01-08
NZ182694A (en) 1978-09-25
NO764222L (fr) 1977-06-23
FR2351984B1 (fr) 1980-06-27
FI763682A (fr) 1977-06-23
ATA217578A (de) 1978-08-15
DK153156B (da) 1988-06-20
ATA948976A (de) 1978-07-15
MX3840E (es) 1981-08-11
HU172474B (hu) 1978-09-28
ZA766957B (en) 1978-06-28
IL50977A (en) 1980-02-29
DE2654647A1 (de) 1977-06-30
RO69709A (fr) 1980-04-15
BE849415A (fr) 1977-06-15
RO75963A (fr) 1981-02-28
IL57386A0 (en) 1979-09-30
JPS6183189A (ja) 1986-04-26
SE424730B (sv) 1982-08-09
JPS5282714A (en) 1977-07-11
NO148887B (no) 1983-09-26
CS195746B2 (en) 1980-02-29
SU671732A3 (ru) 1979-06-30
NL7614233A (nl) 1977-06-24
SE7614401L (sv) 1977-06-23
RO75964A (fr) 1981-02-28
IL57387A0 (en) 1979-09-30
DK153156C (da) 1989-02-20
FR2361898A1 (fr) 1978-03-17
GR65891B (fr) 1980-12-01
DE2654647C2 (de) 1982-06-24
JPS624393B2 (fr) 1987-01-30
PH12191A (en) 1978-11-21
CA1080696A (fr) 1980-07-01
LU76435A1 (fr) 1977-06-10
FR2351985A1 (fr) 1977-12-16
AT349148B (de) 1979-03-26
SE8201701L (sv) 1982-03-17
SE441096B (sv) 1985-09-09
FR2361898B1 (fr) 1980-03-14
FR2351984A1 (fr) 1977-12-16
US4054738A (en) 1977-10-18
PT65955B (en) 1978-06-15
GB1565854A (en) 1980-04-23
IL50977A0 (en) 1977-01-31
SE443564B (sv) 1986-03-03
AU2001376A (en) 1978-06-01
SE8201702L (sv) 1982-03-17
PT65955A (en) 1977-01-01
OA05518A (fr) 1981-04-30
FI66008C (fi) 1984-08-10
DD128727A5 (de) 1977-12-07
CH628348A5 (de) 1982-02-26
AT348678B (de) 1979-02-26
AR213300A1 (es) 1979-01-15
PL102739B1 (pl) 1979-04-30
DK575576A (da) 1977-06-23

Similar Documents

Publication Publication Date Title
SE433208B (sv) Forfarande for framstellning av fenoletrar
RO72997A (fr) Procede pour la preparation des benzoylureido-nitro-diphenylethers
SE7605139L (sv) Forfarande for framstellning av vattenupptagande cellulosaetrar
SE430336B (sv) Forbettrat forfarande for framstellning av amoxicillinfrihydrat
AR217629A1 (es) Procedimiento de preparacion de derivados de tienotetrahidropiridina
AR211273A1 (es) Procendimiento de preparacion de nuevas (fenoxi-4-fenil)1-piperazinas
NO146022C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme benzofenonderivater
NO148887C (no) Fremgangsmaate til fremstilling av det krystallinske anhydrat av natriumcefamandol
NO141893C (no) Fremgangsmaate til fremstilling av perkarboksylsyreopploesninger
NO139555C (no) Fremgangsmaate for fremstilling av fosgen
SE7606116L (sv) Forfarande for framstellning av 3-fenoxidbensaldehyder
SE7604781L (sv) Forfarande for framstellning av diarylhydroxibutylaminer
SE421793B (sv) Analogiforfarande for framstellning naftyridinsubstituerade pyrrolderivat
SE404186B (sv) Forfarande for framstellning av cyklopropanolderivat
SE7607322L (sv) Forfarande for framstellning av 16-etrar av fusidinsyraderivat
SE423814B (sv) Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat
SE446726B (sv) Forfarande for framstellning av 16-metoxiprostaglandiner
SE7610637L (sv) Forfarande for framstellning av 2-alkylindaner
SE7607026L (sv) Forfarande for framstellning av 5-alkylpikolinsyra
SE7605427L (sv) Forfarande for framstellning av klorcyan
SE427037B (sv) Forfarande for framstellning av deoxiklavulansyra
SE7603682L (sv) Forfarande for framstellning av en eteriskt substituerad monosackarid
DK157761C (da) Fremgangsmaade til fremstilling af det krystallinske anhydrat af natriumcefamandol
NO148298C (no) Fremgangsmaate til fremstilling av aminocyklitolforbindelser
SE435288B (sv) Forfarande for framstellning av 7-metoxicefalosporiner